Monk Talks Tisotumab Vedotin and Exciting ESMO Data in Cervical Cancer
Season 5, Episode 44, Sep 23, 2021, 07:59 PM
Dr. Monk discusses the significance of the FDA approval of tisotumab vedotin and notable research that was presented at the 2021 ESMO Congress in cervical cancer.